International Patent: IN VIVO CAR-T THERAPY COMPRISING TARGETING DELIVERY OF RNA BY A NOVEL ANTIBODY-CONJUGATED LNP

GENEVA, July 9 -- STARNA THERAPEUTICS filed a patent application (CN2024/143635) for “IN VIVO CAR-T THERAPY COMPRISING TARGETING DELIVERY OF RNA BY A NOVEL ANTIBODY-CONJUGATED LNP”. With publication no. WO/2026/143319, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....